PCN139 FINAL QUALITY OF LIFE (QOL) RESULTS WITH GEOGRAPHICAL ANALYSIS FOR SUNITINIB VERSUS INTERFERON-ALFA, AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74389-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)74389-8/fulltext
Title :
PCN139 FINAL QUALITY OF LIFE (QOL) RESULTS WITH GEOGRAPHICAL ANALYSIS FOR SUNITINIB VERSUS INTERFERON-ALFA, AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74389-8&doi=10.1016/S1098-3015(10)74389-8
First page :
Section Title :
Open access? :
No
Section Order :
313